(VIANEWS) – SPAREBANKEN ØST (SPOG.OL), WDP (WDP.BR), VISTIN PHARMA (VISTN.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SPAREBANKEN ØST (SPOG.OL)
18.6% sales growth and 10.59% return on equity
Sparebanken Øst operates as a savings bank in Eastern Norway. The company offers financial products, such as savings, credit, and payment products; current accounts; home mortgage loans; and mortgage loans for new and used cars. It also provides vehicles, houses and contents, boats, and leisure insurance products, as well as life and health insurance products; and shares and funds trading services. In addition, the company buys, sells, and stores cryptocurrencies, as well as operates, manages, leases, and sells real estate properties. The company was founded in 1843 and is headquartered in Drammen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN ØST has a trailing twelve months EPS of kr7.76.
PE Ratio
SPAREBANKEN ØST has a trailing twelve months price to earnings ratio of 6.96. Meaning, the purchaser of the share is investing kr6.96 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.59%.
Volume
Today’s last reported volume for SPAREBANKEN ØST is 5512 which is 66.1% below its average volume of 16263.
Moving Average
SPAREBANKEN ØST’s value is higher than its 50-day moving average of kr52.98 and above its 200-day moving average of kr51.03.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 22, 2024, the estimated forward annual dividend rate is 5.4 and the estimated forward annual dividend yield is 9.75%.
More news about SPAREBANKEN ØST.
2. WDP (WDP.BR)
12.5% sales growth and 3.99% return on equity
WDP develops and invests in logistics property (warehouses and offices). WDP has over 7 million m² of properties in its portfolio. This international portfolio of semi-industrial and logistics buildings is spread over about 300 sites at prime logistics hubs for storage and distribution in Belgium, France, the Netherlands, Luxembourg, Germany and Romania.
Earnings Per Share
As for profitability, WDP has a trailing twelve months EPS of €0.11.
PE Ratio
WDP has a trailing twelve months price to earnings ratio of 230.55. Meaning, the purchaser of the share is investing €230.55 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.99%.
Moving Average
WDP’s value is under its 50-day moving average of €26.14 and under its 200-day moving average of €25.64.
Yearly Top and Bottom Value
WDP’s stock is valued at €25.36 at 12:20 EST, way under its 52-week high of €28.94 and way above its 52-week low of €22.16.
Volume
Today’s last reported volume for WDP is 78637 which is 71.84% below its average volume of 279284.
More news about WDP.
3. VISTIN PHARMA (VISTN.OL)
6.6% sales growth and 19.84% return on equity
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.27.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 18.74. Meaning, the purchaser of the share is investing kr18.74 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.84%.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the ongoing quarter and 6.6% for the next.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 6, 2024, the estimated forward annual dividend rate is 1.75 and the estimated forward annual dividend yield is 7.71%.
More news about VISTIN PHARMA.
